L. Kellenberger

发表

Stemming the tide? Advances in antibiotic discovery and development in the face of emerging resistance and financial constraint.

M. Page, L. Kellenberger, Malcolm G P Page, 2012, Current opinion in pharmacology.

Activity of the Novel Macrolide BAL19403 against Ribosomes from Erythromycin-Resistant Propionibacterium acnes

M. Page, L. Kellenberger, J. Dreier, 2007, Antimicrobial Agents and Chemotherapy.

Analysis of a C-methyltransferase gene (aviG1) involved in avilamycin biosynthesis in Streptomyces viridochromogenes Tü57 and complementation of a Saccharopolyspora erythraea eryBIII mutant by aviG1.

S. Gaisser, P. Leadlay, L. Kellenberger, 2002, Microbiology.

A defined system for hybrid macrolide biosynthesis in Saccharopolyspora erythraea

S. Gaisser, P. Leadlay, J. Staunton, 2000, Molecular microbiology.

Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.

A. I. Glushkov, P. Caspers, M. Page, 2010, Bioorganic & medicinal chemistry letters.

Antipropionibacterial Activity of BAL19403, a Novel Macrolide Antibiotic

L. Kellenberger, S. Shapiro, S. Heller, 2007, Antimicrobial Agents and Chemotherapy.

Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models

H. Lane, P. Walker, L. Kellenberger, 2022, Anti-cancer drugs.

A Polylinker Approach to Reductive Loop Swaps in Modular Polyketide Synthases

Guido Sauter, James Staunton, P. Leadlay, 2008, Chembiochem : a European journal of chemical biology.

Novel ketolide antibiotics with a fused five-membered lactone ring--synthesis, physicochemical and antimicrobial properties.

L. Kellenberger, A. Schmitt-Hoffmann, D. Hunziker, 2004, Bioorganic & medicinal chemistry.

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma

H. Lane, S. Braun, L. Kellenberger, 2021, Expert opinion on investigational drugs.

Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272.

Sabine Gaisser, James Staunton, Barrie Wilkinson, 2003, Organic & biomolecular chemistry.

Knowledge-based design of bimodular and trimodular polyketide synthases based on domain and module swaps: a route to simple statin analogues.

P. Leadlay, B. Wilkinson, J. Cortés, 1999, Chemistry & biology.

Stereochemistry of catalysis by the ketoreductase activity in the first extension module of the erythromycin polyketide synthase.

P. Leadlay, J. Cortés, J. Staunton, 2002, Biochemistry.

Abstract C229: BAL27862: A novel anticancer agent which dissociates microtubules and creates a distinct cellular phenotype

H. Lane, L. Kellenberger, F. Bachmann, 2009 .

Elucidation of the in vitro metabolic profile of stable isotope labeled BAL19403 by accurate mass capillary liquid chromatography/quadrupole time-of-flight mass spectrometry and isotope exchange.

L. Kellenberger, M. Donzelli, K. Gebhardt, 2007, Rapid communications in mass spectrometry : RCM.

The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivo

H. Lane, L. Kellenberger, F. Bachmann, 2022, Anti-cancer drugs.

A Polylinker Approach to Reductive Loop Swaps in Modular Polyketide Synthases

P. Leadlay, J. Cortés, J. Staunton, 2008, Chembiochem : a European journal of chemical biology.

Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination

Adrian Brüngger, L. Kellenberger, F. Bachmann, 2024, Frontiers in oncology.